NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor-Reference-Cited by-同舟云学术

NF-κB drives acquired resistance to a novel mutant-selective EGFR inhibitor

Published:2015-04-29 Issue:40 Volume:6 Page:42717-42732
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Galvani Elena¹,Sun Jing²,Leon Leticia G.³,Sciarrillo Rocco¹⁴,Narayan Ravi S.⁵,Tjin Tham Sjin Robert⁶,Lee Kwangho⁶,Ohashi Kadoaki²,Heideman Daniëlle A.M.⁷,Alfieri Roberta R.⁸,Heynen Guus J.⁹,Bernards René⁹,Smit Egbert F.¹⁰,Pao William²,Peters Godefridus J.¹,Giovannetti Elisa¹¹¹

Affiliation:

1. Department Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands

2. Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA

3. Instituto de Tecnologias Biomedicas, Center for Biomedical Research of the Canary Islands, University of La Laguna, Tenerife, Spain

4. Department Hematology, VU University Medical Center, Amsterdam, The Netherlands

5. Department Radiation Oncology, VU University Medical Center, Amsterdam, The Netherlands

6. Celgene Avilomics Research, Bedford, MA, USA

7. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands

8. Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy

9. Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands

10. Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands

11. Cancer Pharmacology Lab, AIRC Start-Up Unit, DIPINT, University of Pisa, Pisa, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Psidium guajava induces cytotoxicity in human malignant glioblastoma cell line: Role of reactive oxygen species;Toxicology in Vitro;2023-06

2. Inhibition of IκB Kinase Is a Potential Therapeutic Strategy to Circumvent Resistance to Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer Cells;Cancers;2022-10-24

3. NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition;Journal of Cellular Physiology;2022-05-13

4. Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance;Frontiers in Oncology;2022-04-07

5. FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in EGFR-Mutant NSCLC Cells;Marine Drugs;2022-01-17